Neshima develops life-saving treatments for severe lung diseases, including pneumonia and COPD, based on a patented liquid foam platform for respiratory drug delivery.
info@embarcventures.com
Home
About Us
Program
FAQ
Contact
Apply
In partnership with:
© 2024 embARC Ventures. All rights reserved. Website by Awaken.
.png)
